Eva Thoma‐Greber
About
In The Last Decade
Eva Thoma‐Greber
15 papers receiving 304 citations
Peers
Comparison fields: 5 of 48
- Epidemiology 152
- Infectious Diseases 124
- Physiology 123
- Public Health, Environmental and Occupational Health 60
- Microbiology 57
Countries citing papers authored by Eva Thoma‐Greber
This map shows the geographic impact of Eva Thoma‐Greber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Thoma‐Greber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Thoma‐Greber more than expected).
Fields of papers citing papers by Eva Thoma‐Greber
This network shows the impact of papers produced by Eva Thoma‐Greber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Thoma‐Greber. The network helps show where Eva Thoma‐Greber may publish in the future.
Co-authorship network of co-authors of Eva Thoma‐Greber
This figure shows the co-authorship network connecting the top 25 collaborators of Eva Thoma‐Greber. A scholar is included among the top collaborators of Eva Thoma‐Greber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Thoma‐Greber. Eva Thoma‐Greber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 31 | |
| 2 | 12 | |
| 3 | 3 | |
| 4 | Is anal carcinoma a HAART-related problem? | 8 |
| 5 | 10 | |
| 6 | 2 | |
| 7 | 52 | |
| 8 | 14 | |
| 9 | 10 | |
| 10 | 46 | |
| 11 | 2 | |
| 12 | Single dose, dose-escalating trial with fozivudine tidoxil (BM 21.1290). | 4 |
| 13 | 2 | |
| 14 | 122 | |
| 15 | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.